×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by LOWE CHRISTOPHER P.

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
VINCVincerx Pharma, Inc.LOWE CHRISTOPHER P.DirectorAug 24, 2022Buy$1.6518,40030,29928,400Aug 26, 2022, 04:06 PM
VINCVincerx Pharma, Inc.LOWE CHRISTOPHER P.DirectorAug 25, 2022Buy$1.6511,60019,13940,000Aug 26, 2022, 04:06 PM
CRTXCortexyme, Inc.LOWE CHRISTOPHER P.COO & Chief Financial OfficerNov 16, 2021Option Exercise$2.2330,00066,90090,000Nov 16, 2021, 08:17 PM
CRTXCortexyme, Inc.LOWE CHRISTOPHER P.COO & Chief Financial OfficerOct 05, 2021Option Exercise$76.679,926761,07664,963Oct 07, 2021, 06:24 PM
CRTXCortexyme, Inc.LOWE CHRISTOPHER P.COO & Chief Financial OfficerAug 16, 2021Sale$48.7744,0002,145,83952,000Aug 18, 2021, 05:25 PM
CRTXCortexyme, Inc.LOWE CHRISTOPHER P.COO & Chief Financial OfficerAug 17, 2021Option Exercise$2.2330,00066,90060,000Aug 18, 2021, 05:25 PM
VINCVincerx Pharma, Inc.LOWE CHRISTOPHER P.DirectorJun 29, 2021Buy$12.596,40080,5766,400Jun 30, 2021, 06:59 PM
VINCVincerx Pharma, Inc.LOWE CHRISTOPHER P.DirectorJun 30, 2021Buy$12.663,60045,57610,000Jun 30, 2021, 06:59 PM
CRTXCortexyme, Inc.LOWE CHRISTOPHER P.COO & Chief Financial OfficerJun 30, 2021Option Exercise$2.2330,00066,90030,000Jun 30, 2021, 05:46 PM
CRTXCortexyme, Inc.LOWE CHRISTOPHER P.COO & Chief Financial OfficerJun 28, 2021Option Exercise$28.1940,0001,127,67420,000Jun 30, 2021, 05:46 PM
HNSNHANSEN MEDICAL INCLOWE CHRISTOPHER P.Interim CFOJul 27, 2016Option Exercise$4.00104,250417,0000Jul 29, 2016, 08:28 PM
HNSNHANSEN MEDICAL INCLOWE CHRISTOPHER P.Interim CEOMay 20, 2014Buy$1.4420,00028,89042,500May 20, 2014, 07:40 PM
HNSNHANSEN MEDICAL INCLOWE CHRISTOPHER P.DirectorMay 13, 2013Buy$1.5212,50019,00022,500May 15, 2013, 04:35 PM
ANTHAnthera Pharmaceuticals IncLOWE CHRISTOPHER P.C.F.O. and C.B.O.Jan 03, 2013Option Exercise$0.698,6605,97541,336Jan 07, 2013, 09:17 PM
ANTHAnthera Pharmaceuticals IncLOWE CHRISTOPHER P.C.F.O. and C.B.O.Feb 01, 2012Sale$7.6615,000114,90031,151Feb 03, 2012, 04:01 PM
ANTHAnthera Pharmaceuticals IncLOWE CHRISTOPHER P.Chief Financial Officer & CBONov 03, 2011Sale$6.8815,000103,23646,151Nov 04, 2011, 08:24 PM
ANTHAnthera Pharmaceuticals IncLOWE CHRISTOPHER P.Chief Financial Officer & CBOOct 25, 2011Sale$7.074,63732,7840Oct 27, 2011, 07:48 PM
ANTHAnthera Pharmaceuticals IncLOWE CHRISTOPHER P.Chief Financial Officer & CBOAug 08, 2011Option Exercise$1.3410,00013,40061,151Aug 09, 2011, 06:21 PM
ANTHAnthera Pharmaceuticals IncLOWE CHRISTOPHER P.Chief Financial Officer & CBOAug 02, 2011Sale$7.315,00036,5714,937Aug 04, 2011, 08:08 PM
ANTHAnthera Pharmaceuticals IncLOWE CHRISTOPHER P.Chief Financial Officer & CBOAug 03, 2011Sale$6.8814,600100,43251,151Aug 04, 2011, 08:08 PM
ANTHAnthera Pharmaceuticals IncLOWE CHRISTOPHER P.Chief Financial Officer & CBOJun 30, 2011Option Exercise$8.1723,500191,99565,751Jul 05, 2011, 06:34 PM
ANTHAnthera Pharmaceuticals IncLOWE CHRISTOPHER P.Chief Financial Officer & CBOJun 21, 2011Option Exercise$1.3120,00026,20087,645Jun 22, 2011, 08:11 PM
ANTHAnthera Pharmaceuticals IncLOWE CHRISTOPHER P.CFO & VP of AdministrationSep 24, 2010Buy$4.185,00020,90062,523Sep 24, 2010, 09:20 PM